Skip to main content
Premium Trial:

Request an Annual Quote

New York State OKs CBLPath's PCR-based Testing Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CBLPath today announced the New York State Department of Health has approved it to offer PCR-based testing of T-cells and B-cells.

Based in Rye Brook, NY, CBLPath provides sub-specialized anatomic pathology and molecular diagnostic laboratory services.

In a statement, David Bryant, CEO of the company, said that the industry is undergoing a convergence of anatomic, molecular, and digital pathology, combined with radiology. "With our added molecular capabilities, CBLPath is able to harness the full power of the convergence to provide better care to patients," he said.

CBLPath will expand its menu of molecular diagnostic tests during the next several months, the company said, without elaborating.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.